Literature DB >> 33422096

Multiorgan failure with fatal outcome after stem cell tourism.

Željka Večerić-Haler1,2, Špela Borštnar3,4, Boštjan Luzar5, Maja Jerše5, Nika Kojc5.   

Abstract

BACKGROUND: Unproven stem cell treatments may involve serious health, personal, and financial considerations. Due to worldwide spread, illegal stem cell therapies have become a major public health problem. We have already witnessed numerous reports in the mass media of severe and occasionally even fatal outcomes after such therapies. However, there are only few scientifically documented cases in which the causality between stem cell therapy and side effects cannot be refuted. CASE
PRESENTATION: Here we present a case report of a 48-year-old patient with serious side effects, including disseminated skin ulcers, hepatitis, and cardiomyopathy, with eventual fatal outcome following unproven stem cell treatment.
CONCLUSIONS: The case of the patient presented here draws attention to the worst possible outcome of stem cell tourism. To effectively combat this issue, professionals and patients should be empowered with the right knowledge on possible side effects.

Entities:  

Keywords:  Calciphylaxis; Cardiomyopathy; Hepatitis; Multiorgan failure; Skin ulcer; Stem cell; Stem cell tourism; Unproven stem cell treatment

Year:  2021        PMID: 33422096     DOI: 10.1186/s40001-020-00477-4

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  2 in total

1.  Calciphylaxis.

Authors:  Sagar U Nigwekar; Ravi Thadhani; Vincent M Brandenburg
Journal:  N Engl J Med       Date:  2018-07-26       Impact factor: 91.245

Review 2.  Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).

Authors:  Karen E Matsukuma; Dongguang Wei; Kai Sun; Rajendra Ramsamooj; Mingyi Chen
Journal:  J Gastrointest Oncol       Date:  2016-04
  2 in total
  1 in total

Review 1.  International stem cell tourism: a critical literature review and evidence-based recommendations.

Authors:  Samantha Lyons; Shival Salgaonkar; Gerard T Flaherty
Journal:  Int Health       Date:  2022-03-02       Impact factor: 2.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.